✦ LIBER ✦

UCN-01 in combination with topotecan in patients with advanced recurrent ovarian cancer: A study of the Princess Margaret Hospital Phase II consortium

✍ Scribed by Stephen Welch; Hal W. Hirte; Mark S. Carey; Sebastian J. Hotte; Ming-Sound Tsao; Shirley Brown; Gregory R. Pond; Janet E. Dancey; Amit M. Oza

Book ID: 113961028
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 182 KB
Volume: 106
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2007.02.018

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase I/II Study of Topotecan in Combi

A Phase I/II Study of Topotecan in Combination with Carboplatin in Recurrent Epithelial Ovarian Cancer

✍ Giorgio Bolis; Giovanna Scarfone; Cesarina Sciatta; Gian Piero Polverino; Cristi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 40 KB

Topotecan combined with carboplatin in r

Topotecan combined with carboplatin in recurrent epithelial ovarian cancer: Results of a single-institutional phase II study

✍ Heeseok Kang; Tae-Joong Kim; Yoo-Young Lee; Chel Hun Choi; Jeong-Won Lee; Duk-So 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 235 KB

Phase II study of weekly topotecan in pa

Phase II study of weekly topotecan in patients with recurrent or persistent epithelial ovarian cancer

✍ Tally Levy; Moshe Inbar; Joseph Menczer; Dan Grisaru; Marek Glezerman; Tamar Saf 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 140 KB

A phase II study of UCN-01 in combinatio

A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer

✍ Cynthia X. Ma, Matthew J. C. Ellis, Gina R. Petroni, Zhanfang Guo, Shi-rong Cai, 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 466 KB

Sorafenib in combination with weekly top

Sorafenib in combination with weekly topotecan in recurrent ovarian cancer, a phase I/II study of the Hoosier Oncology Group

✍ R. Ramasubbaiah; S.M. Perkins; J. Schilder; C. Whalen; C.S. Johnson; M. Callahan 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 268 KB

Weekly combination of topotecan and gemc

Weekly combination of topotecan and gemcitabine in early recurrent ovarian cancer patients: A French multicenter phase II study

✍ F. Joly; T. Petit; P. Pautier; E. Guardiola; F. Mayer; A. Chevalier-Place; R. De 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 403 KB